Beta-lactamase inhibition: therapeutic implications in infectious diseases--an overview.
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
R C
RC
Moellering
D001398:Aztreonam / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000494:pharmacology; D004352:Drug Resistance, Microbial / Q000235:genetics; D006801:Humans; D010403:Penicillin Resistance / Q000235:genetics; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000235:genetics
D002511:Cephalosporins; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases; D001398:Aztreonam